SECURITIES AND EXCHANGE
WASHINGTON, D.C. 20549
FORM 12b-25
Commission file number 0-230 17
NOTIFICATION OF LATE FILING
(Check One): _ Form 10-K _ Form 20-F _ Form 11-K x Form 10-QSB _ Form N-SAR
For Period Ended: June 30, 2002
-------------
__ Transition Report on Form 10-K __ Transition Report on Form 10-Q
__ Transition Report on Form 20-F __ Transition Report on Form N-SAR
__ Transition Report on Form 11-K
For the Transition Period Ended:
-----------------------------------
Read attached instruction sheet before preparing form.
Please print or type.
Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.
If the notification relates to a portion of the filing checked
above, identify the item(s) to which the notification relates: N/A
----------------
PART I
REGISTRANT INFORMATION
Full Name of Registrant: Sontra Medical Corporation
------------------------------
Former Name if Applicable: ChoiceTel Communications, Inc.
------------------------------
Address of principal executive office (Street and Number):
58 Charles Street
City, State and Zip Code: Cambridge, Massachusetts 02141
--------------------------------
PART II
RULES 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable effort
or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate.)
(a) The reasons described in reasonable detail in Part III
of this form could not be eliminated without
unreasonable effort or expense;
(b) The subject annual report, semi-annual report, transition
report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion
thereof will be filed on or before the 15th calendar day
following the prescribed due date; or the subject
quarterly report or transition report on Form 10-Q, or
portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable.
PART III
NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F,
11-K, 10-Q, N-SAR or the transition report portion thereof could not be filed
within the prescribed time period. (Attach Extra Sheets if Needed.)
As a result of the consummation of the business combination on June
20, 2002, by and among the registrant and Sontra Medical, Inc.
(Sontra), whereby the registrant began operating in Sontra's line of
business, the registrant needs more time to the complete its
consolidated financial statements for the quarter ended June 30, 2002
because the registrant's review process with its independent public
accountant could not be completed within the prescribed time period
without the registrant incurring unreasonable effort or expense.
Therefore, the registrant could not file its Form 10-QSB for the
quarter ended June 30, 2002 within the prescribed time period without
incurring unreasonable effort or expense. The registrant expects to
be able to file such Form 10-QSB within the additional time allowed
for such filing pursuant to Rule 12b-25 of the rules and regulations
promulgated by the Securities and Exchange Commission under the
Securities and Exchange Act of 1934, as amended.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification.
Thomas W. Davison 617 494-5337
--------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or
15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period
that the registrant was required to file such report(s) been filed? If answer is
not, identify report(s).
x Yes No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof?
x Yes No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
In connection with the consummation of the business combination
between the registrant and Sontra Medical, Inc. (Sontra), the results
for the quarter reflect the application of reverse merger accounting
principles under generally accepted accounting principles which
provide that the historical results of Sontra's business be treated
as the historical results of the combined entity. Accordingly, the
results for the quarter reflect three months of Sontra's business
together with ten days of the registrant's operations, which occurred
after the transaction closed on June 20, 2002. . The registrant has
no revenues for the quarter ended June 30, 2002, compared with
revenues of $4,886 for the corresponding period a year earlier. The
registrant's net loss for the quarter ended June 30, 2002 is
approximately $750,000 compared with net income of $1,083,230 for the
same period last year
Sontra Medical Corporation
- --------------------------------------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: August 14, 2002 By /s/ Thomas W. Davision
----------------- ---------------------------
Thomas W. Davision
President and Chief Executive Officer